Equities

Renalytix PLC

RENX:LSE

Renalytix PLC

Health CareHealth Care Providers
  • Price (GBX)11.40
  • Today's Change-0.10 / -0.87%
  • Shares traded297.69k
  • 1 Year change-85.29%
  • Beta1.8059
Data delayed at least 20 minutes, as of Jun 28 2024 10:31 BST.
More ▼

IC View

The last IC recommendation on Renalytix PLC shares was Buy at 878.00 on 21 Oct 2021Read the full article

Key statistics

Renalytix PLC (RENX:LSE) set a new 52-week low during Thursday's trading session when it reached 10.00. Over this period, the share price is down -89.87%.
52-week range
Today
10.00Jun 27 2024150.00Jul 13 2023
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open11.00
High13.05
Low11.40
Bid10.00
Offer12.00
Previous close11.50
Average volume468.44k
Shares outstanding154.37m
Free float94.98m
P/E (TTM)--
Market cap19.75m GBP
EPS (TTM)-0.4477 GBP
Data delayed at least 20 minutes, as of Jun 28 2024 10:31 BST.
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.